Skip to content

Clinical trials

Phase 3 Respiratory Distress Syndrome trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Distress Syndrome Phase: Phase 3 Country / region: Canada Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20081
20091
20131
20202
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated5
Completed4
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Aerogen Pharma Limited1
AstraZeneca1
Canadian Critical Care Trials Group1
Hamilton Health Sciences Corporation1
LEO Pharma1
NICHD Neonatal Research Network1
National Heart, Lung, and Blood Institute (NHLBI)1
Ottawa Hospital Research Institute1
Pneuma Pharmaceuticals Incorporated1
University of British Columbia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Distress Syndrome11
COVID-193
Coronavirus Infections3
Severe Acute Respiratory Syndrome3
Lung Diseases2
Acute Kidney Injury1
Acute Lung Injury1
Drowning1
Hypertension, Pulmonary1
Infections1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.